https://doi.org/10.17037/DATA.00002321
Data collected as part of a cross-sectional study of Public Health Workers (PHWs) and Healthcare Workers (HCWs) perceptions of the implementation, practicality of, and barriers to implementation of COVID-19 non-pharmaceutical interventions (NPIs) and pharmaceutical interventions (PIs). It consists of two tabular datasets, one that contain survey responses collected from Public Health Workers, and a second that contains survey responses of Healthcare workers. Variables include data on socio-demographic characteristics and key COVID-19 NPIs and PIs. Each row represents one participant.
The Healthcare Workers Survey Dataset contains the following variables:
Question Number | Question text | Answer code | Answer label |
URN | Anonymised ID number | Integer | |
Q1 | Are you a healthcare professional aged over 18 years and do you agree to take part in this survey? | ||
1 | Yes | ||
2 | No | ||
Q2 | Are any population groups being shielded? | ||
1 | Yes | ||
2 | No | ||
3 | Don't know | ||
Q2_a | Which population groups are being shielded? | ||
1 | Pregnant women | ||
2 | Older people | ||
3 | People who have long-term health conditions (e.g. HIV, diabetes, heart disease) | ||
4 | People who have weakened immune systems (e.g. tuberculosis (TB), cancer or transplant patients) | ||
5 | Don't know | ||
6 | Other | ||
Q2_b | How easy do you think it is to implement shielding measures for pregnant women in terms of practical challenges? | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
Q2_b_i | Which of the following do you think are barriers to implementing shielding measures for pregnant women? | ||
1 | Lack of enforcement | ||
2 | Lack of policies and guidelines | ||
3 | Lack of communication between policy-makers and the public | ||
4 | Lack of communication between healthcare providers and the public | ||
5 | Lack of public support | ||
6 | Lack of home support for pregnant women (e.g. medical care, supply of food/medications) | ||
7 | Lack of financial support for pregnant women | ||
8 | Social stigma | ||
9 | Misinformation (e.g. rumours or myths) | ||
10 | Socio-cultural beliefs and practices | ||
11 | Other | ||
12 | Don't know | ||
Q2_c | How easy do you think it is to implement shielding measures for older people in terms of practical challenges? | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
Q2_c_i | Which of the following do you think are barriers to implementing shielding measures for older people? | ||
1 | Lack of enforcement | ||
2 | Lack of policies and guidelines | ||
3 | Lack of communication between policy-makers and the public | ||
4 | Lack of communication between healthcare providers and the public | ||
5 | Lack of public support | ||
6 | Lack of home support for older people (e.g. medical care, supply of food/medications) | ||
7 | Social stigma | ||
8 | Misinformation (e.g. rumours or myths) | ||
9 | Socio-cultural beliefs and practices | ||
10 | Other | ||
11 | Don't know | ||
Q2_d | How easy do you think it is to implement shielding measures for people with long-term conditions or those with weakened immune systems in terms of practical challenges? | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
Q2_d_i | Which of the following do you think are barriers to implementing shielding measures for people with long-term conditions or those with weakened immune systems? | ||
1 | Lack of enforcement | ||
2 | Lack of policies and guidelines | ||
3 | Lack of communication between policy-makers and the public | ||
4 | Lack of communication between policy-makers and healthcare providers | ||
5 | Lack of communication between healthcare providers and the public | ||
6 | Lack of public support | ||
7 | Lack of home support for people with long-term conditions or those with weakened immune systems (e.g. medical care, supply of food/medications) | ||
8 | Social stigma | ||
9 | Misinformation (e.g. rumours or myths) | ||
10 | Socio-cultural beliefs and practices | ||
11 | Other | ||
12 | Don't know | ||
Q3 | Do you think a vaccine, if developed, should be introduced to prevent COVID-19? | ||
1 | Yes | ||
2 | No | ||
3 | Don't know | ||
Q3_a | Do you think a vaccine should be prioritised for certain popualtion groups (e.g. pregnant women, healthcare workers, older people)? | ||
1 | Yes | ||
2 | No, everyone should be vaccinated | ||
3 | Don't know | ||
Q3_a_i | Which of the following population groups do you think a vaccine should be prioritised for? (please select up to 3 groups) | ||
1 | Infants | ||
2 | School age children | ||
3 | Pregnant women | ||
4 | People who are working | ||
5 | People who are carers for dependents | ||
6 | Older people | ||
7 | People who have long-term health conditions (e.g. diabetes, heart disease) | ||
8 | People who have weakened immune systems (e.g. cancer or transplant patients) | ||
9 | People who are in closed settings (e.g. prisons, long-term care facilities) | ||
10 | People who are displaced (e.g. living in refugee camps) | ||
11 | Healthcare/ Social care/ Emergency professionals | ||
12 | Other | ||
Q3_b | How easy do you think it is to provide a COVID-19 vaccine to these population groups in terms of practical challenges? | ||
Q3_b_1 | Infants | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q3_b_2 | School age children | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q3_b_3 | Pregnant women | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q3_b_4 | People who are working | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q3_b_5 | People who are carers for dependents | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q3_b_6 | Older people | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q3_b_7 | People who have long-term health conditions (e.g. HIV, diabetes, heart disease) | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q3_b_8 | People who have weakened immune systems (e.g. tuberculosis, cancer or transplant patients) | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q3_b_9 | People who are in closed settings (e.g. prisons, long-term care facilities) | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q3_b_10 | People who are displaced (e.g. living in refugee camps) | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q3_b_11 | Healthcare/ Social care/ Emergency professionals | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q3_b_12 | People who are homeless | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q3_c | Which of the following do you think are barriers to implementing a COVID-19 vaccine? | ||
1 | Lack of vaccine supply | ||
2 | Lack of financial support | ||
3 | Lack of policies and guidelines | ||
4 | Lack of trained staff | ||
5 | Lack of communication between healthcare providers and the public | ||
6 | Lack of communication between policy-makers and the public | ||
7 | Lack of public support | ||
8 | Lack of equipment (e.g. cold chain) | ||
9 | Vaccine is manufactured in another country | ||
10 | Public fear of vaccine safety | ||
11 | Public fear of vaccine effectiveness | ||
12 | Socio-cultural beliefs and practices | ||
13 | Social stigma | ||
14 | Don't know | ||
15 | Other | ||
Q4 | Are any medications (drugs) approved for COVID-19 use? | ||
1 | Yes | ||
2 | No | ||
3 | Don't know | ||
4 | Not applicable (NA) - I don't administer or prescribe medications in my profession | ||
Q4_a | Which of the following medications/therapies have been approved to prevent/treat COVID-19 in your country? | ||
1 | Dexamethasone | ||
2 | Chloroquine | ||
3 | Hydroxychloroquine | ||
4 | Remdesivir | ||
5 | Favipiravir | ||
6 | Lopinavir-ritonavir (kaletra) | ||
7 | Interferon beta-1a | ||
8 | Convalescent plasma | ||
9 | Natural/traditional treatments | ||
10 | Other | ||
11 | Don't know | ||
Q4_b | How easy do you think it is to provide a COVID-19 oral treatment in terms of practical challenges? | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
Q4_b_i | Which of the following do you think are barriers to providing a COVID-19 oral treatment? | ||
1 | Lack of policies and guidelines | ||
2 | Lack of communication between policy-makers and healthcare professionals | ||
3 | Lack of communication between healthcare providers and the public | ||
4 | Lack of communication between policy-makers and the public | ||
5 | Lack of public support | ||
6 | Misinformation (e.g. rumours or myths) | ||
7 | Socio-cultural beliefs and practices | ||
8 | Lack of medication supply | ||
9 | Lack of trained staff | ||
10 | Social stigma | ||
11 | Other | ||
12 | Don't know | ||
Q4_c | How easy do you think it is to provide a COVID-19 treatment via an injection in terms of practical challenges? | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
Q4_c_i | Which of the following do you think are barriers to providing a COVID-19 treatment via an injection? | ||
1 | Lack of policies and guidelines | ||
2 | Lack of communication between policy-makers and healthcare professionals | ||
3 | Lack of communication between healthcare providers and the public | ||
4 | Lack of communication between policy-makers and the public | ||
5 | Lack of public support | ||
6 | Misinformation (e.g. rumours or myths) | ||
7 | Socio-cultural beliefs and practices | ||
8 | Lack of medication supply | ||
9 | Lack of equipment to administer treatment (e.g. syringes, needles) | ||
10 | Lack of trained staff | ||
11 | Social stigma | ||
12 | Other | ||
13 | Don't know | ||
Q4_d | How easy do you think it is to provide a COVID-19 intravenous treatment in terms of practical challenges? | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
Q4_d_i | Which of the following do you think are barriers to providing a COVID-19 intravenous treatment? | ||
1 | Lack of policies and guidelines | ||
2 | Lack of communication between policy-makers and healthcare professionals | ||
3 | Lack of communication between healthcare providers and the public | ||
4 | Lack of communication between policy-makers and the public | ||
5 | Lack of public support | ||
6 | Misinformation (e.g. rumours or myths) | ||
7 | Socio-cultural beliefs and practices | ||
8 | Lack of medication supply | ||
9 | Lack of equipment to administer treatment (e.g. infusion pump) | ||
10 | Lack of trained staff | ||
11 | Social stigma | ||
12 | Other | ||
13 | Don't know | ||
Q4_e | How easy do you think it is to provide a COVID-19 inhaled treatment (e.g. via nebuliser) in terms of practical challenges? | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
Q4_e_i | Which of the following do you think are barriers to providing a COVID-19 inhaled treatment? | ||
1 | Lack of policies and guidelines | ||
2 | Lack of communication between policy-makers and healthcare professionals | ||
3 | Lack of communication between healthcare providers and the public | ||
4 | Lack of communication between policy-makers and the public | ||
5 | Lack of public support | ||
6 | Misinformation (e.g. rumours or myths) | ||
7 | Socio-cultural beliefs and practices | ||
8 | Lack of medication supply | ||
9 | Lack of equipment to provide treatment (e.g. nebuliser machine) | ||
10 | Lack of trained staff | ||
11 | Social stigma | ||
12 | Other | ||
13 | Don't know | ||
Q4_f | How easy do you think it is to provide blood products (e.g. transfusion of plasma) for COVID-19 treatment in terms of practical challenges? | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
Q4_f_i | Which of the following do you think are barriers to providing blood products (e.g. transfusion of plasma) for COVID-19 treatment? | ||
1 | Lack of policies and guidelines | ||
2 | Lack of communication between policy-makers and healthcare professionals | ||
3 | Lack of communication between healthcare providers and the public | ||
4 | Lack of communication between policy-makers and the public | ||
5 | Lack of public support | ||
6 | Misinformation (e.g. rumours or myths) | ||
7 | Socio-cultural beliefs and practices | ||
8 | Lack of donors | ||
9 | Lack of equipment to provide treatment (e.g. intravenous pump) | ||
10 | Lack of trained staff | ||
11 | Social stigma | ||
12 | Lack of blood services | ||
13 | Lack of technology infrastructure (e.g. laboratory, cold chain) | ||
14 | Other | ||
15 | Don't know | ||
Q5 | Has the delivery of essential healthcare services been affected? | ||
1 | Yes | ||
2 | No | ||
3 | Don't know | ||
Q5_a | Which of the following essential healthcare services have been affected? | ||
1 | Immunisation programmes | ||
2 | Maternal and Reproductive Health (e.g. facility-based deliveries, antenatal care) | ||
3 | HIV/AIDs | ||
4 | Tuberculosis | ||
5 | Malaria | ||
6 | Auxiliary services (e.g. laboratory and blood bank services, basic diagnostic imaging) | ||
7 | Critical inpatient therapies | ||
8 | Provision of medications and supplies for chronic or communicable diseases | ||
9 | Care for vulnerable populations | ||
10 | Emergency care that requires time-sensitive intervention | ||
11 | Other | ||
Q5_b | How easy do you think it is for the following essential healthcare services to operate as normal in terms of practical challenges? | ||
Q5_b_1 | Immunisation programmes | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very Difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q5_b_2 | Maternal and Reproductive Health (e.g. facility-based deliveries, antenatal care) | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very Difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q5_b_3 | HIV/AIDs | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very Difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q5_b_4 | Tuberculosis | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very Difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q5_b_5 | Malaria | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very Difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q5_b_6 | Auxiliary services (e.g. laboratory and blood bank services, basic diagnostic imaging) | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very Difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q5_b_7 | Critical inpatient therapies | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very Difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q5_b_8 | Provision of medications and supplies for chronic or communicable diseases | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very Difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q5_b_9 | Care for vulnerable populations | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very Difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q5_b_10 | Emergency care that requires time-sensitive intervention | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very Difficult | ||
5 | Don't know | ||
6 | Not applicable (NA) | ||
Q5_c | Do you think there are barriers to providing essential healthcare services? | ||
1 | Yes | ||
2 | No | ||
3 | Don't know | ||
Q5_c_i | Which of the following do you think are barriers to providing essential healthcare services? | ||
1 | Lack of trained staff | ||
2 | Lack of PPE | ||
3 | Lack of supply of treatments/vaccines | ||
4 | Lack of public support | ||
5 | Lack of communication with healthcare providers and the public | ||
6 | Lack of communication between policy-makers and healthcare professionals | ||
7 | Lack of policies and guidelines | ||
8 | Lack of communication with policy-makers and the public | ||
9 | Misinformation (e.g. rumours or myths) | ||
10 | Other | ||
Q6 | Is PPE for COVID-19 being used to perform certain healthcare activities in your place of work? | ||
1 | Yes | ||
2 | No | ||
3 | Don't know | ||
Q6_a | Which PPE for COVID-19 is being used for the following activities? | ||
Q6_a_1 | Providing direct patient care or assistance to suspected COVID-19 patients | ||
1 | Medical masks | ||
2 | N-95/ FFP2/FFP3 masks | ||
3 | Gowns | ||
4 | Gloves | ||
5 | Aprons | ||
6 | Face shields | ||
7 | Goggles/ glasses | ||
8 | None | ||
9 | Don't know | ||
10 | Not applicable (NA) | ||
Q6_a_2 | Providing direct patient care or assistance to confirmed COVID-19 patients | ||
1 | Medical masks | ||
2 | N-95/ FFP2/FFP3 masks | ||
3 | Gowns | ||
4 | Gloves | ||
5 | Aprons | ||
6 | Face shields | ||
7 | Goggles/ glasses | ||
8 | None | ||
9 | Don't know | ||
10 | Not applicable (NA) | ||
Q6_a_3 | Providing direct care to COVID-19 patients in settings where aerosol-generating procedures are frequently performed (e.g. open suctioning, cardiopulmonary resuscitation) | ||
1 | Medical masks | ||
2 | N-95/ FFP2/FFP3 masks | ||
3 | Gowns | ||
4 | Gloves | ||
5 | Aprons | ||
6 | Face shields | ||
7 | Goggles/ glasses | ||
8 | None | ||
9 | Don't know | ||
10 | Not applicable (NA) | ||
Q6_a_4 | Collecting laboratory samples | ||
1 | Medical masks | ||
2 | N-95/ FFP2/FFP3 masks | ||
3 | Gowns | ||
4 | Gloves | ||
5 | Aprons | ||
6 | Face shields | ||
7 | Goggles/ glasses | ||
8 | None | ||
9 | Don't know | ||
10 | Not applicable (NA) | ||
Q6_a_5 | Interviewing and assessing persons with or without symptoms (no direct contact/physical distance of at least 1 metre) | ||
1 | Medical masks | ||
2 | N-95/ FFP2/FFP3 masks | ||
3 | Gowns | ||
4 | Gloves | ||
5 | Aprons | ||
6 | Face shields | ||
7 | Goggles/ glasses | ||
8 | None | ||
9 | Don't know | ||
10 | Not applicable (NA) | ||
Q6_b | How easy do you think it is to implement PPE for COVID-19 to perform healthcare activities in terms of practical challenges? | ||
1 | Very easy | ||
2 | Easy | ||
3 | Difficult | ||
4 | Very difficult | ||
5 | Don't know | ||
Q6_b_i | Which of the following do you think are barriers to implementing PPE for COVID-19 to perform healthcare activities? | ||
1 | Lack of N-95 / FFP2 / FFP3 masks | ||
2 | Lack of medical masks | ||
3 | Lack of eye protection equipment | ||
4 | Lack of gloves | ||
5 | Lack of gowns | ||
6 | Lack of policies and guidelines | ||
7 | Lack of communication between policy-makers and healthcare professionals | ||
8 | Lack of awareness of policies and guidelines among healthcare professionals | ||
9 | Insufficient staff training | ||
10 | Discomfort of wearing PPE | ||
11 | Poor quality of PPE | ||
12 | Misinformation (e.g. rumours or myths) | ||
13 | Socio-cultural beliefs and practices | ||
14 | Social stigma | ||
15 | Other | ||
16 | Don't know | ||
Q7 | What is your profession? | ||
1 | Doctor | ||
2 | Nurse | ||
3 | Midwife | ||
4 | Community health worker | ||
5 | Other | ||
Q8 | What type of health facility do you work at/with? | ||
1 | Community clinic/health post | ||
2 | Government local/district hospital | ||
3 | Government referral hospital | ||
4 | Private community clinic | ||
5 | Private local/district hospital | ||
6 | Private referral hospital | ||
7 | Research institute | ||
8 | Other | ||
Q9 | Please tell us which country you have answered the survey questions for: | ||
1 | Afghanistan | ||
2 | Albania | ||
3 | Algeria | ||
4 | Andorra | ||
5 | Angola | ||
6 | Antigua and Barbuda | ||
7 | Argentina | ||
8 | Armenia | ||
9 | Australia | ||
10 | Austria | ||
11 | Azerbaijan | ||
12 | Bahamas | ||
13 | Bahrain | ||
14 | Bangladesh | ||
15 | Barbados | ||
16 | Belarus | ||
17 | Belgium | ||
18 | Belize | ||
19 | Benin | ||
20 | Bhutan | ||
21 | Bolivia | ||
22 | Bosnia and Herzegovina | ||
23 | Botswana | ||
24 | Brazil | ||
25 | Brunei Darussalam | ||
26 | Bulgaria | ||
27 | Burkina Faso | ||
28 | Burundi | ||
29 | Cabo Verde | ||
30 | Cambodia | ||
31 | Cameroon | ||
32 | Canada | ||
33 | Central African Republic | ||
34 | Chad | ||
35 | Chile | ||
36 | China | ||
37 | Colombia | ||
38 | Comoros | ||
39 | Congo | ||
40 | Costa Rica | ||
41 | Côte d'Ivoire | ||
42 | Croatia | ||
43 | Cuba | ||
44 | Cyprus | ||
45 | Czech Republic | ||
46 | Democratic People's Republic of Korea | ||
47 | Democratic Republic of the Congo | ||
48 | Denmark | ||
49 | Djibouti | ||
50 | Dominica | ||
51 | Dominican Republic | ||
52 | Ecuador | ||
53 | Egypt | ||
54 | El Salvador | ||
55 | Equatorial Guinea | ||
56 | Eritrea | ||
57 | Estonia | ||
58 | Eswatini | ||
59 | Ethiopia | ||
60 | Fiji | ||
61 | Finland | ||
62 | France | ||
63 | Gabon | ||
64 | Gambia (Republic of The) | ||
65 | Georgia | ||
66 | Germany | ||
67 | Ghana | ||
68 | Greece | ||
69 | Grenada | ||
70 | Guatemala | ||
71 | Guinea | ||
72 | Guinea Bissau | ||
73 | Guyana | ||
74 | Haiti | ||
75 | Honduras | ||
76 | Hungary | ||
77 | Iceland | ||
78 | India | ||
79 | Indonesia | ||
80 | Iran (Islamic Republic of) | ||
81 | Iraq | ||
82 | Ireland | ||
83 | Israel | ||
84 | Italy | ||
85 | Jamaica | ||
86 | Japan | ||
87 | Jordan | ||
88 | Kazakhstan | ||
89 | Kenya | ||
90 | Kiribati | ||
91 | Kuwait | ||
92 | Kyrgyzstan | ||
93 | Lao People's Democratic Republic | ||
94 | Latvia | ||
95 | Lebanon | ||
96 | Lesotho | ||
97 | Liberia | ||
98 | Libya | ||
99 | Liechtenstein | ||
100 | Lithuania | ||
101 | Luxembourg | ||
102 | Madagascar | ||
103 | Malawi | ||
104 | Malaysia | ||
105 | Maldives | ||
106 | Mali | ||
107 | Malta | ||
108 | Marshall Islands | ||
109 | Mauritania | ||
110 | Mauritius | ||
111 | Mexico | ||
112 | Micronesia (Federated States of) | ||
113 | Monaco | ||
114 | Mongolia | ||
115 | Montenegro | ||
116 | Morocco | ||
117 | Mozambique | ||
118 | Myanmar | ||
119 | Namibia | ||
120 | Nauru | ||
121 | Nepal | ||
122 | Netherlands | ||
123 | New Zealand | ||
124 | Nicaragua | ||
125 | Niger | ||
126 | Nigeria | ||
127 | North Macedonia | ||
128 | Norway | ||
129 | Oman | ||
130 | Palau | ||
131 | Panama | ||
132 | Papua New Guinea | ||
133 | Paraguay | ||
134 | Peru | ||
135 | Philippines | ||
136 | Poland | ||
137 | Portugal | ||
138 | Qatar | ||
139 | Republic of Korea | ||
140 | Republic of Moldova | ||
141 | Romania | ||
142 | Russian Federation | ||
143 | Rwanda | ||
144 | Saint Kitts and Nevis | ||
145 | Saint Lucia | ||
146 | Saint Vincent and the Grenadines | ||
147 | Samoa | ||
148 | San Marino | ||
149 | Sao Tome and Principe | ||
150 | Saudi Arabia | ||
151 | Senegal | ||
152 | Serbia | ||
153 | Seychelles | ||
154 | Sierra Leone | ||
155 | Singapore | ||
156 | Slovakia | ||
157 | Slovenia | ||
158 | Solomon Islands | ||
159 | Somalia | ||
160 | South Africa | ||
161 | South Sudan | ||
162 | Spain | ||
163 | Sri Lanka | ||
164 | Sudan | ||
165 | Suriname | ||
166 | Sweden | ||
167 | Switzerland | ||
168 | Syrian Arab Republic | ||
169 | Tajikistan | ||
170 | Thailand | ||
171 | Timor-Leste | ||
172 | Togo | ||
173 | Tonga | ||
174 | Trinidad and Tobago | ||
175 | Tunisia | ||
176 | Turkey | ||
177 | Turkmenistan | ||
178 | Tuvalu | ||
179 | Uganda | ||
180 | Ukraine | ||
181 | United Arab Emirates | ||
182 | United Kingdom of Great Britain and Northern Ireland | ||
183 | United Republic of Tanzania | ||
184 | United States of America | ||
185 | Uruguay | ||
186 | Uzbekistan | ||
187 | Vanuatu | ||
188 | Venezuela, Bolivarian Republic of | ||
189 | Vietnam | ||
190 | Yemen | ||
191 | Zambia | ||
192 | Zimbabwe | ||
193 | Other | ||
Q10 | What is your age? | ||
1 | 18 - 35 | ||
2 | 35 - 44 | ||
3 | 45 - 54 | ||
4 | 55 - 64 | ||
5 | 65 - 74 | ||
6 | 75 and over | ||
7 | Prefer not to say | ||
Q11 | What is your gender? | ||
1 | Male | ||
2 | Female | ||
3 | Transgender | ||
4 | Another gender | ||
5 | Prefer not to say |